A detailed history of Harbour Investments, Inc. transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Harbour Investments, Inc. holds 2,754 shares of EW stock, worth $181,240. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,754
Previous 2,758 0.15%
Holding current value
$181,240
Previous $254,000 28.74%
% of portfolio
0.01%
Previous 0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$59.7 - $93.78 $238 - $375
-4 Reduced 0.15%
2,754 $181,000
Q2 2024

Jul 26, 2024

SELL
$84.3 - $94.31 $1,011 - $1,131
-12 Reduced 0.43%
2,758 $254,000
Q1 2024

Jul 22, 2024

SELL
$72.54 - $95.56 $62,529 - $82,372
-862 Reduced 23.73%
2,770 $264,000
Q4 2023

Feb 16, 2024

BUY
$61.71 - $77.76 $29,065 - $36,624
471 Added 14.9%
3,632 $276,000
Q3 2023

Nov 15, 2023

BUY
$69.28 - $93.38 $40,875 - $55,094
590 Added 22.95%
3,161 $218,000
Q2 2023

Aug 14, 2023

BUY
$81.41 - $94.33 $895 - $1,037
11 Added 0.43%
2,571 $242,000
Q1 2023

May 15, 2023

SELL
$74.26 - $84.51 $297 - $338
-4 Reduced 0.16%
2,560 $211,000
Q4 2022

Feb 15, 2023

SELL
$68.3 - $87.44 $8,264 - $10,580
-121 Reduced 4.51%
2,564 $191,000
Q2 2022

Aug 15, 2022

SELL
$86.5 - $128.27 $78,715 - $116,725
-910 Reduced 25.31%
2,685 $255,000
Q4 2021

Feb 16, 2022

SELL
$106.37 - $130.68 $379,102 - $465,743
-3,564 Reduced 49.78%
3,595 $466,000
Q3 2021

Nov 15, 2021

SELL
$102.91 - $122.75 $397,747 - $474,428
-3,865 Reduced 35.06%
7,159 $810,000
Q2 2021

Aug 16, 2021

SELL
$83.84 - $104.76 $9,306 - $11,628
-111 Reduced 1.0%
11,024 $1.14 Million
Q1 2021

Aug 17, 2021

BUY
$78.68 - $90.67 $679,716 - $783,298
8,639 Added 346.11%
11,135 $931,000
Q1 2021

May 12, 2021

BUY
$78.68 - $90.67 $196,385 - $226,312
2,496 New
2,496 $209,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $40.7B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Harbour Investments, Inc. Portfolio

Follow Harbour Investments, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harbour Investments, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Harbour Investments, Inc. with notifications on news.